T
Teresa Schmidt
Researcher at University Hospital Bonn
Publications - 27
Citations - 143
Teresa Schmidt is an academic researcher from University Hospital Bonn. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 13 publications receiving 63 citations. Previous affiliations of Teresa Schmidt include University of Duisburg-Essen.
Papers
More filters
Journal ArticleDOI
Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016.
Sied Kebir,Manuel Weber,Lazaros Lazaridis,Cornelius Deuschl,Teresa Schmidt,Christoph Mönninghoff,Kathy Keyvani,Lale Umutlu,Daniela Pierscianek,Michael Forsting,Ulrich Sure,Martin Stuschke,Christoph Kleinschnitz,Björn Scheffler,Patrick M. Colletti,Domenico Rubello,Christoph Rischpler,Martin Glas +17 more
TL;DR: MET-PET/MRI imaging in pre-operatively classifying glioma entities appears useful for the assessment of IDH status, however, a larger trial is needed prior to translation into the clinical routine.
Journal ArticleDOI
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
Lazaros Lazaridis,Niklas Schäfer,Sarah Teuber-Hanselmann,Tobias Blau,Teresa Schmidt,Christoph Oster,Johannes Weller,Theophilos Tzaridis,Daniela Pierscianek,Kathy Keyvani,Christoph Kleinschnitz,Martin Stuschke,Björn Scheffler,Cornelius Deuschl,Ulrich Sure,Ulrich Herrlinger,Sied Kebir,Martin Glas +17 more
TL;DR: This analysis provides first indication that the combination of TTFields/lomustine/temozolomide is safe and feasible, and the observed survival outcomes might suggest potential beneficial effects.
Journal ArticleDOI
A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma.
Sied Kebir,Teresa Schmidt,Matthias Weber,Lazaros Lazaridis,Norbert Galldiks,Karl-Josef Langen,Christoph Kleinschnitz,Elke Hattingen,Ulrich Herrlinger,Philipp Lohmann,Martin Glas +10 more
TL;DR: In IDH-wildtype glioblastoma, ML-based PSP detection leads to better diagnostic performance and is shown to offer great potential particularly when multiparametric data is available.
Journal ArticleDOI
Regorafenib in patients with recurrent high-grade astrocytoma.
Sied Kebir,Laurèl Rauschenbach,Alexander Radbruch,Lazaros Lazaridis,Teresa Schmidt,Ann-Kathrin Stoppek,Daniela Pierscianek,Martin Stuschke,Michael Forsting,Ulrich Sure,Kathy Keyvani,Christoph Kleinschnitz,Björn Scheffler,Martin Glas +13 more
TL;DR: This retrospective study indicates a very poor performance of regorafenib in recurrent high-grade astrocytoma with a fairly high number of CTC°3 adverse events, and regorAFenib does not seem to bear a potential for infiltrative tumor growth promotion.
Journal ArticleDOI
Comparison of L-Methyl-11C-Methionine PET With Magnetic Resonance Spectroscopy in Detecting Newly Diagnosed Glioma.
Sied Kebir,Lazaros Lazaridis,Manuel Weber,Cornelius Deuschl,Ann-Kathrin Stoppek,Teresa Schmidt,Christoph Mönninghoff,Tobias Blau,Kathy Keyvani,Lale Umutlu,Daniela Pierscianek,Michael Forsting,Martin Stuschke,Gerald Antoch,Ulrich Sure,Christoph Kleinschnitz,Björn Scheffler,Patrick M. Colletti,Domenico Rubello,Ken Herrmann,Martin Glas +20 more
TL;DR: L-Methyl-11C-methionine PET appears to be superior in differentiating IDH status, whereas MRS is more helpful in glioma subgrouping.